Where BoomRx fits in the pharmacy stack
Compounded and manufactured medications for cash-pay clinics flow through a fixed chain: the prescriber authorizes the order, a procurement platform routes it, a licensed pharmacy makes or sources it, and a carrier delivers it. BoomRx occupies the procurement-platform layer across 503A compounders, 503B outsourcing facilities, and brand manufacturers — it does not hold a pharmacy license and does not compound, so questions about fill quality and certificates of analysis belong to the partner pharmacies, while questions about pricing visibility, patient-linked checkout, and per-line audit belong to the platform.
Fizy Health sits in the same ordering layer but targets a different ops pattern. It resolves per-vial 503A cost on each catalog and cart line before checkout, runs cart validation — SIGs, prescriber state licensure, and stock — before payment, and ties every line to a specific patient with HIPAA audit on each mutation. BoomRx solves vendor fragmentation; Fizy Health solves refill day when patient-linked batch checkout matters more than 503B breadth.